Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 2019-2025
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/canada-ibd-inflammatory-bowel-disease-market
Canada IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. Canada IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. On the basis of diagnostics, the market segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.
A Full Report of Global IoT Sensors Market is Available at: https://www.omrglobal.com/industry-reports/canada-ibd-inflammatory-bowel-disease-market
Canada IBD Market by Disease Type
• Ulcerative Colitis
• Crohn’s Disease
Canada IBD Market by Diagnostics
• Blood and Stool Tests
Canada IBD Market by Therapeutics
• Anti- Inflammatory Drug Administration
• Biological Drugs
• Amino salicylates
• Abbott Laboratories
• AbbVie Inc.
• Accesa Labs
• Boehringer Ingelheim International GmbH
• Celgene Corp.
• Eli Lilly and Co.
• Johnson & Johnson Services Inc.
• Laboratory Corporation of America Holdings
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/canada-ibd-inflammatory-bowel-disease-market
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 2019-2025 here
News-ID: 2382086 • Views: 82
More Releases from Orion Market Reports
Pancreatic Cancer Therapy Market Size, Share, Growth, Trends, Analysis and Forec …
The Global Pancreatic Cancer Therapy Market is expected to reach US$ 4,056.4 Mn in 2027 from US$ 2,011.2 Mn in 2017. The market is estimated to grow with a CAGR of 8% from 2021-2027. Pancreatic cancer begins when cells in the pancreas grow out of control. Pancreatic cancer can be divided into two types, exocrine tumors and endocrine tumors, depending on the type of cells affected. These tumors behave differently. So
Insulin Pumps Market Analysis By Industry Size, Share, Revenue Growth and Demand …
The Global Insulin Pumps Market size was valued at 3.30 billion in 2018 and is projected to expand at a CAGR of 9% during the forecast period 2021-2027. Insulin pumps are used to control insulin in people with diabetes at specific intervals. An insulin pump is attached to the person's body and insulin is administered through a catheter inserted under the skin. The pump delivers a certain amount of insulin to
Surgical Suture Market By Size, Demand Analysis, Type, Statistics, Regions and F …
The Global Surgical Suture Market is projected to reach USD 4.9 billion by 2026 from USD 3.7 billion in 2021, at a CAGR of 6% from 2021 to 2027. Surgical sutures, commonly called needles, use a needle to which a length of thread is attached. Surgical sutures are used to close wounds such as skin ulcers, neuropathic ulcers, pediatric heart surgery, and diabetic ulcers. These sutures cause less reaction and provide
Bone Cement Market Size, Share, Analysis, Applications, Growth Insight, Trends, …
The Global Bone Cement Market was valued at about USD 1.2 billion in 2020. The industry is further anticipated to grow at a CAGR of 8% to attain a value of USD 1.9 billion by 2027 over the forecast period of 2021-2027. Bone cement is used by surgeons to secure implants in various orthopedic and traumatic surgeries. Bone cement acts as a filler to create a narrow space that holds the
More Releases for IBD
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios. Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per
Indian IBD Therapeutics Market Growth, Opportunity, Size, Share and Forecast 201 …
Indian IBD therapeutics market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The Indian pharmaceutical industry has been consistently growing with the public and private investments, making India as a potential market for the treatment of prevailing diseases such as IBD. Additionally, healthcare expenditure is playing a critical role in fueling the IBD therapeutics market in India. Request a Free Sample of our
Germany IBD Therapeutics Market will experience a noticeable growth during the f …
Germany IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.4% during the forecast period. The growing IBD patient population in the region is one of the major driving forces for the growth of the market in the country. According to the national institutes of health, the prevalence of Crohn's disease in Germany was estimated to be 322 per 100,000 in Germany in 2018. Moreover, the
Canada IBD Therapeutics Market, Industry Trends, Size, Competitive Analysis and …
Canada IBD Therapeutics market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,
Inflammatory Bowel Disease (IBD) Treatment Market will Exhibit a Steady 2.6% CAG …
Competition is expected to remain high from 2017 to 2025 in the global inflammatory bowel disease (IBD) treatment market. During this time, the market will witness a slew of launches as manufacturers invest in the development of novel therapeutics. According to a new study by Transparency Market Research (TMR), a paradigm shift toward biosimilar and biologic drugs is expected, which will offer a fresh burst of opportunities to the global